Program

Issues: Counterfeiting of medical products threaten public health and the integrity of health systems at the global level. Counterfeiting is a global phenomenon and its scale increases significantly every year. The development of technologies at all stages of the supply chain increases the criminals’ ability to produce, transport and deliver dangerous counterfeit medical products to customers, who do not realize this is a counterfeit product. This important issue requires the international response and is the subject of the Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health (Medicrime Convention). It was signed in Moscow in 2011. Currently, it has been signed by 28 countries and ratified by 14 countries including the Russian Federation.

Moderators:

Pavle Zelich, International Officer, Medicines and Medical Devices Agency

Sergey Glagolev, Deputy Head of division — Head of the department for monitoring the efficiency and safety of medical products, Department of the state quality control of medical products, Federal Service for Surveillance in Healthcare

Lynda Scammell, Senior Advisor, Medicines and Healthcare products Regulatory Agency

Speakers:

Andrey Gayderov, Deputy Head, Department of international cooperation and public affairs, Ministry of Healthcare of the Russian Federation

Ekaterina Nikiforova, Head of the department for inspection of medicines production, State Institute of Medicines and Good Practices, Minpromtorg of Russia

Ines duPlessis, Scientific Officer, Biological standardization department, Network of official medicines laboratories (OMCLs), European Directorate for the Quality of Medicines and Healthcare (EDQM) of the Council of Europe, Curator of the Committee of Experts CMED (on minimization of risks from the counterfeit medical products) and adoption of the Council of Europe ‘Medicrime’ Convention

Mkrtych Shakaryan, Head of good pharmaceutical practice department of the Drug Quality Control Laboratory, Scientific center of drug and medical technology expertise named after academian E. Gabrielyan of the Ministry of the Healthcare of the Republic of Armenia, Member of the Committee of Experts on minimization of risks from the counterfeit medical products and similar crimes of the Council of Europe

Lynda Scammell, Senior Advisor, Medicines and Healthcare products Regulatory Agency in the United Kingdom

Jan Van den Boeynants, Senior Detective, Federal Police of Belgium

Michael Dietz, Head of Drug Control and Safety department, World Health Organization

Pavle Zelich, International Officer, Medicines and Medical Devices Agency

David Shore, Senior Director of Global Security, EMEA Region, PFIZER

Valentin Kiselevich, Ph.D., Manager for counterfeit products inspection, Security department, Sanofi Russia

Richard Bergstrom, Vice-President for pharma, SICPA